Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Gene ; 641: 151-160, 2018 Jan 30.
Artigo em Inglês | MEDLINE | ID: mdl-29045822

RESUMO

Enhancers and insulators are involved in the regulation of gene expression, but the basic underlying mechanisms of action of these elements are unknown. We analyzed the individual effects of the enhancer and the insulator from Drosophila mobile elements copia [enh(copia)] and gypsy using transfected genetic constructs in S2 cells. This system excludes the influence of genomic cis regulatory elements. The enhancer-induced synthesis of 350-1050-nt-long enhancer RNAs (eRNAs) and H3K4me3 and H3K18ac marks, mainly in the region located about 300bp downstream of the enhancer. Insertion of the insulator between the enhancer and the promoter reduced these effects. We also observed the binding of dCTCF to the enhancer and to gypsy insulator. Our data indicate that a single gypsy insulator interacts with both the enhancer and the promoter, while two copies of the gypsy insulator preferentially interact with each other. Our results suggest the formation of chromatin loops that are shaped by the enhancer and the insulator.


Assuntos
Cromatina/genética , Proteínas de Drosophila/genética , Drosophila/genética , Elementos Facilitadores Genéticos/genética , Marcadores Genéticos/genética , Elementos Isolantes/genética , Peptídeo Hidrolases/genética , RNA/genética , Retroelementos/genética , Animais , Células Cultivadas , Regulação da Expressão Gênica/genética , Regiões Promotoras Genéticas/genética , Elementos Reguladores de Transcrição/genética , Transfecção/métodos
2.
Mol Ther Nucleic Acids ; 8: 330-344, 2017 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-28918033

RESUMO

RNAi has been suggested for use in gene therapy of HIV/AIDS, but the main problem is that HIV-1 is highly variable and could escape attack from the small interfering RNAs (siRNAs) due to even single nucleotide substitutions in the potential targets. To exhaustively check the variability in selected RNA targets of HIV-1, we used ultra-deep sequencing of six regions of HIV-1 from the plasma of two independent cohorts of patients from Russia. Six RNAi targets were found that are invariable in 82%-97% of viruses in both cohorts and are located inside the domains specifying reverse transcriptase (RT), integrase, vpu, gp120, and p17. The analysis of mutation frequencies and their characteristics inside the targets suggests a likely role for APOBEC3G (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G, A3G) in G-to-A mutations and a predominant effect of RT biases in the detected variability of the virus. The lowest frequency of mutations was detected in the central part of all six targets. We also discovered that the identical RNAi targets are present in many HIV-1 strains from many countries and from all continents. The data are important for both the understanding of the patterns of HIV-1 mutability and properties of RT and for the development of gene therapy approaches using RNAi for the treatment of HIV/AIDS.

3.
AIDS Res Hum Retroviruses ; 33(2): 194-201, 2017 02.
Artigo em Inglês | MEDLINE | ID: mdl-27476852

RESUMO

Any method for silencing the activity of the HIV-1 retrovirus should tackle the extremely high variability of HIV-1 sequences and mutational escape. We studied sequence variability in the vicinity of selected RNA interference (RNAi) targets from isolates of HIV-1 subtype A in Russia, and we propose that using artificial RNAi is a potential alternative to traditional antiretroviral therapy. We prove that using multiple RNAi targets overcomes the variability in HIV-1 isolates. The optimal number of targets critically depends on the conservation of the target sequences. The total number of targets that are conserved with a probability of 0.7-0.8 should exceed at least 2. Combining deep sequencing and multitarget RNAi may provide an efficient approach to cure HIV/AIDS.


Assuntos
Antivirais/metabolismo , Variação Genética/efeitos dos fármacos , Genótipo , Infecções por HIV/virologia , HIV-1/classificação , HIV-1/efeitos dos fármacos , Interferência de RNA , Células HEK293 , HIV-1/genética , HIV-1/isolamento & purificação , Sequenciamento de Nucleotídeos em Larga Escala , Humanos , Lipossomos/metabolismo , RNA Interferente Pequeno/metabolismo , Federação Russa
4.
Sci Rep ; 6: 25866, 2016 05 10.
Artigo em Inglês | MEDLINE | ID: mdl-27160357

RESUMO

Endogenous hot spots of DNA double-strand breaks (DSBs) are tightly linked with transcription patterns and cancer genomics(1,2). There are nine hot spots of DSBs located in human rDNA units(3-6). Here we describe that the profiles of these hot spots coincide with the profiles of γ-H2AX or H2AX, strongly suggesting a high level of in vivo breakage inside rDNA genes. The data were confirmed by microscopic observation of the largest γ-H2AX foci inside nucleoli in interphase chromosomes. In metaphase chromosomes, we observed that only some portion of rDNA clusters possess γ-H2AX foci and that all γ-H2AX foci co-localize with UBF-1 binding sites, which strongly suggests that only active rDNA units possess the hot spots of DSBs. Both γ-H2AX and UBF-1 are epigenetically inherited and thus indicate the rDNA units that were active in the previous cell cycle. These results have implications for diverse fields, including epigenetics and cancer genomics.


Assuntos
Quebras de DNA de Cadeia Dupla , DNA Ribossômico/genética , Linhagem Celular , Nucléolo Celular/genética , Nucléolo Celular/metabolismo , Epigênese Genética , Células HEK293 , Histonas/metabolismo , Humanos , Hibridização in Situ Fluorescente , Células Jurkat , Proteínas Pol1 do Complexo de Iniciação de Transcrição/metabolismo
5.
Gene ; 583(1): 78-83, 2016 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-26947394

RESUMO

Highly active antiretroviral therapy has greatly reduced the morbidity and mortality of AIDS. However, many of the antiretroviral drugs are toxic with long-term use, and all currently used anti-HIV agents generate drug-resistant mutants. Therefore, there is a great need for new approaches to AIDS therapy. RNAi is a powerful means of inhibiting HIV-1 production in human cells. We propose to use RNAi for gene therapy of HIV/AIDS. Previously we identified a number of new biologically active siRNAs targeting several moderately conserved regions in HIV-1 transcripts. Here we analyze the heterogeneity of nucleotide sequences in three RNAi targets in sequences encoding the reverse transcriptase and integrase domains of current isolates of HIV-1 subtype A in Russia. These data were used to generate genetic constructs expressing short hairpin RNAs 28-30-bp in length that could be processed in cells into siRNAs. After transfection of the constructs we observed siRNAs that efficiently attacked the selected targets. We expect that targeting several viral genes important for HIV-1 reproduction will help overcome the problem of viral adaptation and will prevent the appearance of RNAi escape mutants in current virus strains, an important feature of gene therapy of HIV/AIDS.


Assuntos
HIV-1/genética , Interferência de RNA , Sequência de Bases , Sequência Conservada , Células HEK293 , HIV-1/isolamento & purificação , Humanos , RNA Interferente Pequeno/genética , Federação Russa , Transfecção
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...